The majority of studies evaluating whether Metinflex is associated with obesity, have used a cross-sectional design limiting our comprehension about whether Metinflex develops with fat mass increase leading to insulin resistance. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.